A pharmacist who wants to modernize their pharmacy, a laboratory looking to outsource its pharmacovigilance, a wholesaler facing new digital obligations: they all share the same observation. Services dedicated to professionals in the pharmaceutical sector have significantly diversified in recent years, far beyond the simple supply of medications.
Digital prescriptions and digital services in pharmacies
The digital transition in the pharmaceutical sector is not limited to inventory management software. It now affects the relationship between prescriber, pharmacist, and patient through a central tool: the digital prescription.
In practical terms, this dematerialized prescription replaces the paper document with a secure transmission between the doctor and the pharmacy. The pharmacist receives the prescription directly in their system, which reduces reading errors and speeds up dispensing.
The “My Pharmacy in France” project, led by La Poste Santé & Autonomie, illustrates this evolution well. Entering the pilot phase in about forty pharmacies, it offers pharmacists a common digital solution that integrates prescription transmission, appointment scheduling, and home delivery of medications. A secure messaging system also allows for direct exchanges with patients.
Artificial intelligence features for detecting prescription fraud are already being tested. This type of tool opens up an entirely new range of services for pharmacies and their industrial partners. To explore services for professionals on Pharmanco, this context of digitalization gives an idea of the scale of current needs.
Outsourced pharmacovigilance and regulatory affairs
Have you noticed how much the regulatory obligations on a pharmaceutical laboratory have increased? Between post-marketing surveillance, managing reports of adverse effects, and updating marketing authorization (MA) files, pharmacovigilance mobilizes considerable resources.
This is why outsourcing these functions has become a full-fledged service. Specialized providers take care of:
- Writing and maintaining regulatory files, including the technical modules required by health authorities
- Continuous monitoring of adverse effects reported by healthcare professionals and patients, with periodic reporting to agencies
- Auditing existing files to identify non-compliance before an inspection
- Regulatory watch on changes in European and French standards that affect a drug’s lifecycle
For a small laboratory or a foreign company wishing to market a product in France, using these services allows access to the market without having to build a complete internal regulatory team. Outsourcing significantly reduces the time to compliance.
Continuing education and skill development for pharmacy teams
The pharmacist profession is evolving. The new tasks assigned to pharmacists (vaccination, screening, prescription renewals under certain conditions) require skills that were not part of the initial curriculum just a few years ago.
Continuing education services for professionals in the pharmaceutical sector now cover a wide range of areas. Some modules focus on dispensing biosimilar medications, while others address supporting patients with chronic conditions.
What training platforms offer to pharmacists
Formats have changed. Short online modules are gradually replacing in-person seminars. A pharmacist or a technician can take a thirty-minute training session on managing drug interactions between two patients.
Training organizations also incorporate practical cases drawn from real situations in pharmacies. The goal is not to accumulate hours of mandatory training, but to meet a concrete need: knowing how to manage a new clinical situation or mastering a recently deployed digital tool.
Medical visit networks and business development for laboratories
A laboratory launching a new drug in France needs to quickly reach prescribers and pharmacists. Building an internal sales force represents a heavy investment, especially for overseas markets or areas with low medical density.
Providers today offer outsourced medical visit networks, with representatives already established locally. These teams know the healthcare players in their territory and have the required certifications (medical visit diploma, professional card).
This outsourcing model covers several levels of intervention:
- Medical promotion to hospital and private prescribers
- Sales in pharmacies with support for product listing
- Deployment of Medical Science Liaisons (MSL) for specialized products requiring in-depth scientific dialogue
Access to DROM-COM remains a particular logistical challenge that few laboratories can tackle alone. Providers with offices and storage areas in these territories offer a direct operational advantage.
Market access strategy and distribution
Beyond medical visits, some services include product environment analysis, defining a market access strategy, and handling physical distribution. For a foreign laboratory, these integrated services significantly simplify entry into the French market.
The French pharmaceutical sector is undergoing a period of accelerated transformation. Between the digitization of exchanges in pharmacies, the strengthening of regulatory requirements, and the diversification of pharmacists’ missions, services for professionals are no longer an addition but a condition for operation. Structures that rely on these specialized resources save time on their core business: patient care and health.